Methods for the treatment of polycystic ovary syndrome
AssigneesInstitute of Zoology, Chinese Academy of Sciences, Center for Reproducitive Medicine, Shandong Provincial Hospital, Shandong University
InventorsXiaoxue YUAN, Tao HU, Yuanyuan HUANG, Wanzhu JIN, Zi-Jiang CHEN
Life of this patent
Estimating the term…
Abstract
Polycystic ovary syndrome (PCOS) is a complex and heterogeneous endocrine syndrome associated with a high risk for the development of insulin resistance, type 2 diabetes (T2D), obesity, dyslipidemia, and cardiovascular disease. There are no known therapies for the 9-18% of women afflicted with PCOS. Provided herein are methods for the treatment and/or prevention of at least one symptom of PCOS. Also provided herein are methods for the treatment and/or prevention of PCOS.
Claims13
A method for the treatment, delay of progression, or prevention of at least one symptom of polycyctic ovary syndrome, the method comprising increasing brown adipose tissue activity in a subject in need thereof, wherein at least one symptom of polycystic ovary syndrome is reduced.
A method for the treatment, delay of progression, or prevention of polycystic ovary syndrome, the method comprising increasing brown adipose tissue activity in a subject in need thereof, wherein at least one symptom of polycystic ovary syndrome is reduced.
A method for the treatment, delay of progression, or prevention of polycystic ovary syndrome, the method comprising administration of adiponectin to a subject in need thereof, wherein at least one symptom of polycystic ovary syndrome is reduced.
Dependencies are inferred from the claim text.